-
SentinelOne's Q3 Momentum Meets A Softer Q4 Outlook
Friday, December 5, 2025 - 1:34pm | 372Read More...While SentinelOne Inc's (NYSE:S) fiscal third-quarter results reflect "solid execution" by the company, the fourth-quarter outlook is impacted by "large seasonality," deal timing, and an uncertain macro backdrop, according to Needham. The SentinelOne Analyst: Analyst Mike Cikos reiterated a Buy...
-
Docusign Posts Q3 Beat; Outlook Reflects Revenue Deceleration
Friday, December 5, 2025 - 12:31pm | 398Read More...Shares of Docusign Inc (NASDAQ:DOCU) tanked in early trading on Friday, even after the company reported upbeat third-quarter results. Here are some key analyst takeaways: JPMorgan analyst Mark Murphy maintained a Neutral rating, while reducing the price target from $80 to $78. Needham analyst...
-
Solid Biosciences: Better Positioned To Compete In DMD Gene Therapy, Says Bullish Analyst
Thursday, December 4, 2025 - 4:38pm | 372Read More...Recent deaths of two patients with Duchenne muscular dystrophy (DMD) have opened the doors for emerging gene therapies, such as Solid Biosciences Inc's (NASDAQ:SLDB) SGT-003, according to Needham. The Solid Biosciences Analyst: Analyst Gil Blum initiated coverage with a Buy rating and price target...
-
UiPath Breaks Its Growth Slowdown, Analysts Say Q3 Marks A Turning Point
Thursday, December 4, 2025 - 4:06pm | 492Read More...Shares of UiPath Inc. (NYSE:PATH) jumped on Thursday, after the company reported upbeat third-quarter results on Wednesday. UiPath stock is showing exceptional strength. Why is PATH stock up today? Here are some key analyst takeaways: Canaccord Genuity analyst Kingsley Crane reiterated a Buy...
-
Snowflake Q3 AI Momentum Spikes Bookings 50%; Upside Falls Short Of Q2
Thursday, December 4, 2025 - 3:12pm | 1569Read More...Shares of Snowflake Inc. (NYSE:SNOW) tanked in early trading on Thursday, even after the company reported upbeat third-quarter results on Wednesday. Here are some key analyst takeaways: Cantor Fitzgerald analyst Thomas Blakey reaffirmed an Overweight rating; price target increased from $275 to $...
-
Why C3.ai Q2 Revenue Beat Impresses Analysts
Thursday, December 4, 2025 - 3:10pm | 787Read More...C3.ai Inc (NYSE:AI) shares rose in early trading on Thursday, after the company on Wednesday reported upbeat fiscal second-quarter results. • AI shares are advancing steadily. Watch the momentum here. Here are some key analyst takeaways: Wedbush analyst Dan Ives reaffirmed an Outperform...
-
Salesforce's Q3 Wins Broad Analyst Praise As AI Momentum Builds
Thursday, December 4, 2025 - 1:07pm | 921Read More...Shares of Salesforce Inc. (NYSE:CRM) rose in early trading on Thursday, after the company reported upbeat third-quarter results on Wednesday. Here are some key analyst takeaways: Canaccord Genuity analyst David Hynes maintained a Buy rating and price target of $300. JPMorgan analyst Mark Murphy...
-
Okta Beats Q3, But Slowing Growth Tempers Analyst Enthusiasm
Wednesday, December 3, 2025 - 12:46pm | 525Read More...Shares of Okta Inc (NASDAQ:OKTA) rose in early trading on Wednesday, after the company reported upbeat fiscal third-quarter results. Here are some key analyst takeaways: Scotiabank analyst Patrick Colville maintained a Sector Perform rating, while reducing the price target from $105 to $85....
-
MongoDB Stock Soars, 9 Analysts Hike Estimates After Blockbuster Results
Tuesday, December 2, 2025 - 1:31pm | 1267Read More...MongoDB Inc (NASDAQ:MDB) shares climbed in early trading on Tuesday after the company reported upbeat fiscal third-quarter results. • MDB is approaching key resistance levels. Check the market position here. Here are some key analyst takeaways: Cantor Fitzgerald analyst Thomas Blakey...
-
Beta Bets On Big Skies: Analyst Says Aircraft Milestones, Tech Give Early Edge In $1 Trillion Market
Monday, December 1, 2025 - 12:40pm | 531Read More...Electric aircraft manufacturer Beta Technologies Inc. (NYSE:BETA) completed its initial public offering on the New York Stock Exchange in November, raising over $1 billion. Here are some takeaways from analyst initiation notes: BTIG analyst Andre Madrid started coverage with a Buy rating and a $40...
-
Analog Devices Posts Q3 Beat; Secular Tailwinds, Cyclical Recovery Sets The Stage For FY26 Upside, Analysts Say
Wednesday, November 26, 2025 - 2:20pm | 520Read More...Shares of Analog Devices Inc (NASDAQ:ADI) climbed in early trading on Wednesday after the company reported upbeat third-quarter earnings. Here are some key analyst takeaways: JPMorgan analyst Harlan Sur maintained an Overweight rating, while raising the price target from $310 to $320. Benchmark...
-
Zscaler Posts Q1 Beat, Red Canary Contribution Disappoints Investors
Wednesday, November 26, 2025 - 1:16pm | 777Read More...Shares of Zscaler Inc (NASDAQ:ZS) tanked in early trading on Wednesday, even after the company reported upbeat fiscal first-quarter earnings. Here are some key analyst takeaways: Needham analyst Mike Cikos maintained a Buy rating, while reducing the price target from $350 to $310. RBC Capital...
-
Workday Posts Q3 Beat, Analysts Cut Price Targets On Outlook
Wednesday, November 26, 2025 - 12:12pm | 735Read More...Shares of Workday Inc (NASDAQ:WDAY) tanked in early trading on Wednesday, even after the company reported upbeat third-quarter earnings. Here are some key analyst takeaways: RBC Capital Markets analyst Rishi Jaluria maintained an Outperform rating, while reducing the price target from $340 to $...
-
Zoom Delivers Beat-And-Raise Quarter; AI/CX Growth Engines Are 'Firing On All Cylinders,' Analysts Say
Tuesday, November 25, 2025 - 11:44am | 399Read More...Shares of Zoom Communications Inc (NASDAQ:ZM) climbed in early trading on Tuesday, after the company reported upbeat third-quarter earnings. Here are some key analyst takeaways: Needham analyst Joshua Reilly maintained a Buy rating and price target of $100. Rosenblatt Securities analyst Catharine...
-
Symbotic Posts Strong Q4 And Enters Health-Care Market With First Customer
Tuesday, November 25, 2025 - 11:23am | 397Read More...Symbotic Inc (NASDAQ:SYM) ended the fiscal year on a strong note, with upbeat fourth-quarter results, and announced its first customer in the health care vertical, according to Needham. The Symbotic Analyst: Analyst James Ricchiuti reiterated a Buy rating and raised the price target from $57 to $70...
















